These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 19458010

  • 1. Utilization of immunoglobulin G Fc receptors by human immunodeficiency virus type 1: a specific role for antibodies against the membrane-proximal external region of gp41.
    Perez LG, Costa MR, Todd CA, Haynes BF, Montefiori DC.
    J Virol; 2009 Aug; 83(15):7397-410. PubMed ID: 19458010
    [Abstract] [Full Text] [Related]

  • 2. Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1.
    Zwick MB, Jensen R, Church S, Wang M, Stiegler G, Kunert R, Katinger H, Burton DR.
    J Virol; 2005 Jan; 79(2):1252-61. PubMed ID: 15613352
    [Abstract] [Full Text] [Related]

  • 3. Antibody-DEPENDENT, FcγRI-mediated neutralization of HIV-1 in TZM-bl cells occurs independently of phagocytosis.
    Perez LG, Zolla-Pazner S, Montefiori DC.
    J Virol; 2013 May; 87(9):5287-90. PubMed ID: 23408628
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of HIV-1 neutralization by antibodies targeting a membrane-proximal region of gp41.
    Chen J, Frey G, Peng H, Rits-Volloch S, Garrity J, Seaman MS, Chen B.
    J Virol; 2014 Jan; 88(2):1249-58. PubMed ID: 24227838
    [Abstract] [Full Text] [Related]

  • 5. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10.
    Nelson JD, Brunel FM, Jensen R, Crooks ET, Cardoso RM, Wang M, Hessell A, Wilson IA, Binley JM, Dawson PE, Burton DR, Zwick MB.
    J Virol; 2007 Apr; 81(8):4033-43. PubMed ID: 17287272
    [Abstract] [Full Text] [Related]

  • 6. The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat.
    Montefiori DC, Filsinger Interrante MV, Bell BN, Rubio AA, Joyce JG, Shiver JW, LaBranche CC, Kim PS.
    Proc Natl Acad Sci U S A; 2021 Jan 19; 118(3):. PubMed ID: 33431684
    [Abstract] [Full Text] [Related]

  • 7. Neutralizing epitopes in the membrane-proximal external region of HIV-1 gp41 are influenced by the transmembrane domain and the plasma membrane.
    Montero M, Gulzar N, Klaric KA, Donald JE, Lepik C, Wu S, Tsai S, Julien JP, Hessell AJ, Wang S, Lu S, Burton DR, Pai EF, Degrado WF, Scott JK.
    J Virol; 2012 Mar 19; 86(6):2930-41. PubMed ID: 22238313
    [Abstract] [Full Text] [Related]

  • 8. N-terminal residues of an HIV-1 gp41 membrane-proximal external region antigen influence broadly neutralizing 2F5-like antibodies.
    Li D, Liu J, Zhang L, Xu T, Chen J, Wang L, Zhao Q.
    Virol Sin; 2015 Dec 19; 30(6):449-56. PubMed ID: 26715302
    [Abstract] [Full Text] [Related]

  • 9. Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment.
    Luo M, Yuan F, Liu Y, Jiang S, Song X, Jiang P, Yin X, Ding M, Deng H.
    Vaccine; 2006 Jan 23; 24(4):435-42. PubMed ID: 16143433
    [Abstract] [Full Text] [Related]

  • 10. Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles.
    Phogat S, Svehla K, Tang M, Spadaccini A, Muller J, Mascola J, Berkower I, Wyatt R.
    Virology; 2008 Mar 30; 373(1):72-84. PubMed ID: 18155743
    [Abstract] [Full Text] [Related]

  • 11. A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1.
    Lai RP, Hock M, Radzimanowski J, Tonks P, Hulsik DL, Effantin G, Seilly DJ, Dreja H, Kliche A, Wagner R, Barnett SW, Tumba N, Morris L, LaBranche CC, Montefiori DC, Seaman MS, Heeney JL, Weissenhorn W.
    J Biol Chem; 2014 Oct 24; 289(43):29912-26. PubMed ID: 25160627
    [Abstract] [Full Text] [Related]

  • 12. In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadth.
    Shen X, Parks RJ, Montefiori DC, Kirchherr JL, Keele BF, Decker JM, Blattner WA, Gao F, Weinhold KJ, Hicks CB, Greenberg ML, Hahn BH, Shaw GM, Haynes BF, Tomaras GD.
    J Virol; 2009 Apr 24; 83(8):3617-25. PubMed ID: 19193787
    [Abstract] [Full Text] [Related]

  • 13. IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis.
    Duchemin M, Khamassi M, Xu L, Tudor D, Bomsel M.
    Front Immunol; 2018 Apr 24; 9():244. PubMed ID: 29651286
    [Abstract] [Full Text] [Related]

  • 14. The broadly neutralizing anti-human immunodeficiency virus type 1 4E10 monoclonal antibody is better adapted to membrane-bound epitope recognition and blocking than 2F5.
    Huarte N, Lorizate M, Maeso R, Kunert R, Arranz R, Valpuesta JM, Nieva JL.
    J Virol; 2008 Sep 24; 82(18):8986-96. PubMed ID: 18596094
    [Abstract] [Full Text] [Related]

  • 15. Enhancing HIV-1 Neutralization by Increasing the Local Concentration of Membrane-Proximal External Region-Directed Broadly Neutralizing Antibodies.
    Kim S, Filsinger Interrante MV, Kim PS.
    J Virol; 2023 Jan 31; 97(1):e0164722. PubMed ID: 36541800
    [Abstract] [Full Text] [Related]

  • 16. Antigp41 membrane proximal external region antibodies and the art of using the membrane for neutralization.
    Cerutti N, Loredo-Varela JL, Caillat C, Weissenhorn W.
    Curr Opin HIV AIDS; 2017 May 31; 12(3):250-256. PubMed ID: 28422789
    [Abstract] [Full Text] [Related]

  • 17. Induction of HIV neutralizing antibodies against the MPER of the HIV envelope protein by HA/gp41 chimeric protein-based DNA and VLP vaccines.
    Ye L, Wen Z, Dong K, Wang X, Bu Z, Zhang H, Compans RW, Yang C.
    PLoS One; 2011 May 31; 6(5):e14813. PubMed ID: 21625584
    [Abstract] [Full Text] [Related]

  • 18. Estimating the probability of polyreactive antibodies 4E10 and 2F5 disabling a gp41 trimer after T cell-HIV adhesion.
    Hu B, Liao HX, Alam SM, Goldstein B.
    PLoS Comput Biol; 2014 Jan 31; 10(1):e1003431. PubMed ID: 24499928
    [Abstract] [Full Text] [Related]

  • 19. Passively transmitted gp41 antibodies in babies born from HIV-1 subtype C-seropositive women: correlation between fine specificity and protection.
    Diomede L, Nyoka S, Pastori C, Scotti L, Zambon A, Sherman G, Gray CM, Sarzotti-Kelsoe M, Lopalco L.
    J Virol; 2012 Apr 31; 86(8):4129-38. PubMed ID: 22301151
    [Abstract] [Full Text] [Related]

  • 20. Prolonged exposure of the HIV-1 gp41 membrane proximal region with L669S substitution.
    Shen X, Dennison SM, Liu P, Gao F, Jaeger F, Montefiori DC, Verkoczy L, Haynes BF, Alam SM, Tomaras GD.
    Proc Natl Acad Sci U S A; 2010 Mar 30; 107(13):5972-7. PubMed ID: 20231447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.